IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 39 di 39
Titolo Data di pubblicazione Autore(i) File
Characterization of the sensory, affective, cognitive, biochemical, and neuronal alterations in a modified chronic constriction injury model of neuropathic pain in mice 1-gen-2020 Medeiros, P.; de Freitas, R. L.; Boccella, S.; Iannotta, M.; Belardo, C.; Mazzitelli, M.; Romano, R.; De Gregorio, D.; Coimbra, N. C.; Palazzo, E.; Maione, S.
Behavioral, biochemical and electrophysiological changes in spared nerve injury model of neuropathic pain 1-gen-2020 Guida, F.; De Gregorio, D.; Palazzo, E.; Ricciardi, F.; Boccella, S.; Belardo, C.; Iannotta, M.; Infantino, R.; Formato, F.; Marabese, I.; Luongo, L.; de Novellis, V.; Maione, S.
Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry 1-gen-2021 De Gregorio, D.; Ruggeri, M.; Bhattacharyya, S.; Colizzi, M.
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice 1-gen-2021 Inserra, A.; De Gregorio, D.; Rezai, T.; Lopez-Canul, M. G.; Comai, S.; Gobbi, G.
Hallucinogens in mental health: Preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine 1-gen-2021 de Gregorio, D.; Aguilar-Valles, A.; Preller, K. H.; Heifets, B. D.; Hibicke, M.; Mitchell, J.; Gobbi, G.
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms 1-gen-2021 Inserra, A.; De Gregorio, D.; Gobbi, G.
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission 1-gen-2021 de Gregorio, D.; Popic, J.; Enns, J. P.; Inserra, A.; Skalecka, A.; Markopoulos, A.; Posa, L.; Lopez-Canul, M.; Qianzi, H.; Lafferty, C. K.; Britt, J. P.; Comai, S.; Aguilar-Valles, A.; Sonenberg, N.; Gobbi, G.
Antidepressant actions of ketamine engage cell-specific translation via eIF4E 1-gen-2021 Aguilar-Valles, A.; De Gregorio, D.; Matta-Camacho, E.; Eslamizade, M. J.; Khlaifia, A.; Skaleka, A.; Lopez-Canul, M.; Torres-Berrio, A.; Bermudez, S.; Rurak, G. M.; Simard, S.; Salmaso, N.; Gobbi, G.; Lacaille, J. -C.; Sonenberg, N.
Acute and Chronic Pain Preclinical Models to Study the Analgesic Properties of Melatonergic Compounds 1-gen-2022 De Gregorio, D.; Comai, S.
Hypnotic Effects of Melatonergic Compounds Measured in Mice or Rats 1-gen-2022 Comai, S.; De Gregorio, D.
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder 1-gen-2022 Markopoulos, A.; Inserra, A.; De Gregorio, D.; Gobbi, G.
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs 1-gen-2022 Solmi, M.; Chen, C.; Daure, C.; Buot, A.; Ljuslin, M.; Verroust, V.; Mallet, L.; Khazaal, Y.; Rothen, S.; Thorens, G.; Zullino, D.; Gobbi, G.; Rosenblat, J.; Husain, M. I.; De Gregorio, D.; Castle, D.; Sabe, M.
Supraspinal melatonin MT2 receptor agonism alleviates pain via a neural circuit that recruits mu opioid receptors 1-gen-2022 Posa, L.; De Gregorio, D.; Lopez-Canul, M.; He, Q.; Darcq, E.; Rullo, L.; Pearl-Dowler, L.; Luongo, L.; Candeletti, S.; Romualdi, P.; Kieffer, B. L.; Gobbi, G.
Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling 1-gen-2022 Inserra, A.; Campanale, A.; Cheishvili, D.; Dymov, S.; Wong, A.; Marcal, N.; Syme, R. A.; Taylor, L.; De Gregorio, D.; Kennedy, T. E.; Szyf, M.; Gobbi, G.
Editorial: Methods and applications in addiction psychiatry research: 2021 1-gen-2022 Colizzi, M.; De Gregorio, D.
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline 1-gen-2022 De Gregorio, D.; Inserra, A.; Enns, J. P.; Markopoulos, A.; Pileggi, M.; El Rahimy, Y.; Lopez-Canul, M.; Comai, S.; Gobbi, G.
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome 1-gen-2023 Inserra, A.; Giorgini, G.; Lacroix, S.; Bertazzo, A.; Choo, J.; Markopolous, A.; Grant, E.; Abolghasemi, A.; De Gregorio, D.; Flamand, N.; Rogers, G.; Comai, S.; Silvestri, C.; Gobbi, G.; Di Marzo, V.
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study 1-gen-2023 Tassan Mazzocco, M.; Pisanu, C.; Russo, L.; Acconcia, C.; Cambiaghi, M.; De Girolamo, S.; Squassina, A.; Cherchi, L.; Monzani, E.; Scebba, F.; Angeloni, D.; De Gregorio, D.; Nasini, S.; Dall'Acqua, S.; Sut, S.; Suprani, F.; Garzilli, M.; Guiso, B.; Pulcinelli, V.; Iaselli, M. N.; Pinna, I.; Somaini, G.; Arru, L.; Corrias, C.; Paribello, P.; Pinna, F.; Gobbi, G.; Valtorta, F.; Carpiniello, B.; Manchia, M.; Comai, S.
Acanthoscurria gomesiana spider-derived Mygalin in the prelimbic prefrontal cortex modulates neuropathic pain and depression comorbid 1-gen-2023 Medeiros, A. C.; Medeiros, P.; Ruggiero, R. N.; De Gregorio, D.; Gobbi, G.; Silva Junior, P. I.; dos Santos, W. F.; Coimbra, N. C.; de Freitas, R. L.
Mostrati risultati da 21 a 39 di 39
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile